USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Vital Signs - Next-Generation Sequencing Services Market: An Expanding Role in Clinical Applications Opens New Markets
Vital Signs - Next-Generation Sequencing Services Market: An Expanding Role in Clinical Applications Opens New Markets
RELEASE DATE
30-Mar-2012
30-Mar-2012
REGION
North America
North America
Deliverable Type
Market Research
Market Research
Research Code: 9561-00-DB-00-00
SKU: HC00645-NA-MR_04118
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
HC00645-NA-MR_04118
Description
This issue of Vital Signs, released on March 30, 2012, provides a strategic insight on the next-generation sequencing services market.
Additionally, a company spotlight is provided for Foundation Medicine. Founded in 2010, the cancer diagnostics firm aims to transform cancer care by including comprehensive molecular analysis of tumors from next-generation sequencing to the diagnostic process. Reimbursement and regulatory news from the FDA is also provided for week of March 12, 2012.
Table of Contents
This week's issue
Growth dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Popular Topics
This issue of Vital Signs, released on March 30, 2012, provides a strategic insight on the next-generation sequencing services market. Additionally, a company spotlight is provided for Foundation Medicine. Founded in 2010, the cancer diagnostics firm aims to transform cancer care by including comprehensive molecular analysis of tumors from next-generation sequencing to the diagnostic process. Reimbursement and regulatory news from the FDA is also provided for week of March 12, 2012.
| Deliverable Type | Market Research |
|---|---|
| No Index | Yes |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | 9561-00-DB-00-00 |
| Is Prebook | No |